Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Exp Neurol. 2008 May 29;213(1):114–121. doi: 10.1016/j.expneurol.2008.05.014

Table1.

Clinical data on AD patients and non-demented control subjects. The numbers of neuritic plaques per 2.35 mm2 microscopic field were counted in Aβ anti body stained sections of inferior parietal lobule (the value for each subject is the mean of counts of the 5 most involved fields in each section). PMI, postmortem interval.

Patients Age (years) Gender PMI (h) Neuritic plaques Cause of death Braak stage
Control
1 85 Male 2.00 5.6 Unknown 3
2 86 Female 2.25 7.6 Unknown 2
3 91 Female 4.00 10.4 Unknown 1
4 86 Female 3.75 7.8 Cardiovascular disease 1
5 81 Male 2.00 13.4 Pulmonary embolism 2
6 87 Male 2.40 0.2 Prostate cancer 2
7 82 Male 2.10 1.2 Congestive heart failure, pneumonia 1
8 74 Male 4.00 0.0 Congestive heart failure 1
9 76 Female 2.00 0.0 Chronic obstructive pulmonary disease 1
10 79 Male 1.75 16.2 Bladder cancer 2
Mean±S.D. 82.7±5.3 Male 2.62±0.91 6.24±5.89
Alzheimer's disease
1 83 Female 4.00 24.6 Aspiration pneumonia 6
2 86 Male 4.25 23.4 Bowel obstruction 6
3 78 Female 3.75 34.2 Unknown 6
4 90 Female 2.60 30.4 Unknown 6
5 75 Male 2.33 19.0 Congestive heart failure 6
6 81 Female 3.00 17.4 Unknown 6
7 86 Male 3.25 19.4 Respiratory infection 6
8 74 Male 3.00 27.2 Fall 6
9 84 Male 4.50 34.8 Unknown 6
10 84 2.75 31.4 Aspiration pneumonia 6
Mean±S.D. 82.1±4.8 3.34±0.74 26.18±6.41